Preventing recurrent depression: long-term treatment for major depressive disorder.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of Clinical Psychiatry

• Publication date

  2007-03-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.4088/JCP.0307E06PMID 17388700
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• New goals in the treatment of depression: moving toward recovery.

  2015cited by this paper
• Noradrenergic augmentation of escitalopram response by risperidone: electrophysiologic studies in the rat brain.

  2007cited by this paper
• Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE).

  2006cited by this paper
• Higher Costs and Therapeutic Factors Associated With Adherence to NCQA HEDIS Antidepressant Medication Management Measures: Analysis of Administrative Claims

  2006cited by this paper
• Selective Serotonin-Reuptake Inhibitors and Risk of Persistent Pulmonary Hypertension of the Newborn

  2006cited by this paper
• The Can-SAD study: a randomized controlled trial of the effectiveness of light therapy and fluoxetine in patients with winter seasonal affective disorder.

  2006cited by this paper
• Effects of a Cognitive‐Behavioural Internet Program on Depression, Vulnerability to Depression and Stigma in Adolescent Males: A School‐Based Controlled Trial

  2006cited by this paper
• Psychotropic Drugs in Pregnancy and Lactation

  2006cited by this paper
• Bupropion: pharmacology and therapeutic applications

  2006cited by this paper
• Imipramine is effective in preventing relapse in electroconvulsive therapy-responsive depressed inpatients with prior pharmacotherapy treatment failure: a randomized, placebo-controlled trial.

  2006cited by this paper
• O sweet spot where art thou? Light treatment of Seasonal Affective Disorder and the circadian time of sleep.

  2006cited by this paper
• Developmental and Behavioral Consequences of Prenatal Fluoxetine

  2006cited by this paper
• Pregnancy, depression, antidepressants and breast-feeding.

  2006cited by this paper
• Online randomized controlled trial of brief and full cognitive behaviour therapy for depression

  2006cited by this paper
• Low-Fat Dietary Pattern and Risk of Cardiovascular Disease: The Women's Health Initiative Randomized Controlled Dietary Modification Trial

  2006cited by this paper
• Continuation and maintenance electroconvulsive therapy for the treatment of depressive illness: a response to the National Institute for Clinical Excellence report.

  2006cited by this paper
• Computerised cognitive behaviour therapy for depression and anxiety update: a systematic review and economic evaluation.

  2006cited by this paper
• Substance use disorder comorbidity in major depressive disorder: a confirmatory analysis of the STAR*D cohort.

  2006cited by this paper
• Clinical characteristics of depressed patients with comorbid diabetes mellitus

  2006cited by this paper
• The safety of psychotropic drug use during pregnancy: a review.

  2005cited by this paper
• Chronic coadministration of olanzapine and fluoxetine activates locus coeruleus neurons in rats: implications for bipolar disorder

  2005cited by this paper
• Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis

  2005cited by this paper
• Epidemiology, etiology, and natural treatment of seasonal affective disorder.

  2005cited by this paper
• The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence.

  2005cited by this paper
• Comorbid anxiety and depression.

  2005cited by this paper
• Telephone-administered psychotherapy for depression.

  2005cited by this paper
• Depression in pregnancy and the postpartum period: balancing adverse effects of untreated illness with treatment risks.

  2005cited by this paper
• The impact of residual symptoms on outcome of major depression

  2005cited by this paper
• Pharmacotherapy of depression in pregnancy.

  2004cited by this paper
• Reintroduction of Antidepressant Therapy across Pregnancy in Women Who Previously Discontinued Treatment

  2004cited by this paper
• Six-year outcome of cognitive behavior therapy for prevention of recurrent depression.

  2004influential reference
• Extended-release venlafaxine in relapse prevention for patients with major depressive disorder.

  2004cited by this paper
• Relapse of depression during pregnancy following antidepressant discontinuation: a preliminary prospective study

  2004influential reference
• The Benefits of Exercise for the Clinically Depressed.

  2004cited by this paper
• Cost-effectiveness of computerised cognitive-behavioural therapy for anxiety and depression in primary care: Randomised controlled trial

  2004cited by this paper
• Impact of medical comorbid disease on antidepressant treatment of major depressive disorder

  2004cited by this paper
• Relationship of variability in residual symptoms with recurrence of major depressive disorder during maintenance treatment.

  2004cited by this paper
• Telephone psychotherapy and telephone care management for primary care patients starting antidepressant treatment: a randomized controlled trial.

  2004cited by this paper
• A randomized, placebo-controlled trial of sertraline for prophylactic treatment of highly recurrent major depressive disorder.

  2004cited by this paper
• Cognitive-behavioral analysis system of psychotherapy as a maintenance treatment for chronic depression.

  2004cited by this paper
• Long-term side effects of SSRIs: sexual dysfunction and weight gain.

  2003cited by this paper
• Treating depression to remission.

  2003cited by this paper
• Prevention of relapse and recurrence in depression: the role of long-term pharmacotherapy and psychotherapy.

  2003cited by this paper
• The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression.

  2003cited by this paper
• Achieving remission and managing relapse in depression.

  2003cited by this paper
• Epidemiology of comorbid coronary artery disease and depression.

  2003cited by this paper
• Continuation treatment of chronic depression: a comparison of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination.

  2003cited by this paper
• Rationale and options for the long‐term treatment of depression

  2002cited by this paper
• Pharmacotherapy to sustain the fully remitted state.

  2002cited by this paper
• Depression during pregnancy: diagnosis and treatment options.

  2002cited by this paper
• Effects of Serotonin (5-Hydroxytryptamine, 5-HT) Reuptake Inhibition Plus 5-HT2A Receptor Antagonism on the Firing Activity of Norepinephrine Neurons

  2002cited by this paper
• Treatment approaches to major depressive disorder relapse. Part 1: dose increase.

  2002cited by this paper
• Metacognitive awareness and prevention of relapse in depression: empirical evidence.

  2002cited by this paper
• Optimizing outcomes in depression: focus on antidepressant compliance

  2002cited by this paper
• Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study.

  2002cited by this paper
• Side Effects after Phototherapy Implementation in Addition to Fluoxetine or Sertraline Treatment: A Report of Two Cases

  2002cited by this paper
• Treatment approaches to major depressive disorder relapse. Part 2: reinitiation of antidepressant treatment.

  2002influential reference
• Clinical importance of long-term antidepressant treatment

  2001cited by this paper
• Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial.

  2001influential reference
• Prophylactic effect of citalopram in unipolar, recurrent depression: placebo-controlled study of maintenance therapy.

  2001cited by this paper
• A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression.

  2000cited by this paper
• Progressive attenuation of the firing activity of locus coeruleus noradrenergic neurons by sustained administration of selective serotonin reuptake inhibitors.

  2000cited by this paper
• Effects of cognitive therapy on psychological symptoms and social functioning in residual depression

  2000cited by this paper
• Does incomplete recovery from first lifetime major depressive episode herald a chronic course of illness?

  2000cited by this paper
• Prevention of Recurrent Depression With Cognitive Behavioral Therapy—Reply

  1999cited by this paper
• Running enhances neurogenesis, learning, and long-term potentiation in mice.

  1999cited by this paper
• Serotonin reuptake inhibitor antidepressants and pregnancy: many unanswered questions.

  1999cited by this paper
• Course and cost of treatment for depression with fluoxetine, paroxetine, and sertraline.

  1999cited by this paper
• Epidemiology and diagnosis of depression in late life.

  1999cited by this paper
• Double-blind, placebo-substitution study of nefazodone in the prevention of relapse during continuation treatment of outpatients with major depression.

  1999cited by this paper
• Running increases cell proliferation and neurogenesis in the adult mouse dentate gyrus

  1999cited by this paper
• The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression.

  1998cited by this paper
• Well-being therapy. A novel psychotherapeutic approach for residual symptoms of affective disorders

  1998influential reference
• Implications of failing to achieve successful long-term maintenance treatment of recurrent unipolar major depression.

  1998cited by this paper
• Treating major depression in primary care practice: an update of the Agency for Health Care Policy and Research Practice Guidelines.

  1998cited by this paper
• Maintenance phase efficacy of sertraline for chronic depression: a randomized controlled trial.

  1998cited by this paper
• Fluvoxamine prevents recurrence of depression: results of a long‐term, double‐blind, placebo‐controlled study

  1998cited by this paper
• Major depressive disorder: a prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse.

  1998cited by this paper
• Prophylactic efficacy of phenelzine and imipramine in chronic atypical depression: likelihood of recurrence on discontinuation after 6 months' remission.

  1997cited by this paper
• Moclobemide and fluoxetine in treatment of seasonal affective disorder.

  1996cited by this paper
• Maintenance therapy for chronic depression. A controlled clinical trial of desipramine.

  1996cited by this paper
• The Role of the Primary Care Physician in Patients' Adherence to Antidepressant Therapy

  1995cited by this paper
• Anxiety symptom relief in depression treatment outcomes.

  1995cited by this paper
• The structure of psychological well-being revisited.

  1995cited by this paper
• Multicenter, placebo-controlled study of fluoxetine in seasonal affective disorder.

  1995cited by this paper
• Long-term treatment of depression

  1994influential reference
• Guidelines for the long-term treatment of depression.

  1994cited by this paper
• Paroxetine is better than placebo in relapse prevention and the prophylaxis of recurrent depression

  1993cited by this paper
• How long should the elderly take antidepressants? A double-blind placebo-controlled study of continuation/prophylaxis therapy with dothiepin. Old Age Depression Interest Group.

  1993cited by this paper
• Cognition and life stress in depression: cognitive factors and the definition, rating, and generation of negative life events.

  1993cited by this paper
• Comparison of full-dose versus half-dose pharmacotherapy in the maintenance treatment of recurrent depression.

  1993cited by this paper
• A 24‐week study of 20 mg citalopram, 40 mg citalopram, and placebo in the prevention of relapse of major depression

  1993cited by this paper
• Discontinuation of benzodiazepine treatment: efficacy of cognitive-behavioral therapy for patients with panic disorder.

  1993cited by this paper
• Imipramine treatment of panic disorder with agoraphobia: the second time around.

  1993cited by this paper
• Sertraline in the Prevention of Depression

  1992cited by this paper
• Efficacy of interpersonal psychotherapy as a maintenance treatment of recurrent depression. Contributing factors.

  1991cited by this paper
• Continuation and maintenance treatment of major depression with the monoamine oxidase inhibitor phenelzine: a double-blind placebo-controlled discontinuation study.

  1991cited by this paper
• CONTINUATION AND MAINTENANCE THERAPY WITH ANTIDEPRESSIVE AGENTS : META-ANALYSIS OF RESEARCH(II). AUTHOR'S REPLY

  1991cited by this paper
• Five-year outcome for maintenance therapies in recurrent depression.

  1990cited by this paper
• Three-year outcomes for maintenance therapies in recurrent depression.

  1990influential reference

• The Underestimated Role of the Sports Psychiatrist in Athletic Performance Restoration, Maintenance, and Enhancement in Sports

  2024cites this paper
• Relationship of depression and sleep quality, diseases and general characteristics

  2022cites this paper
• Altered electroencephalography resting state network coherence in remitted MDD.

  2021cites this paper
• Identifying mismatch and match between clinical needs and mental healthcare use trajectories in people with anxiety and depression: Results of a longitudinal study.

  2021cites this paper
• Judging Mental Health Disorders Using Decision Tree Models

  2021cites this paper
• Help-Seeking Patterns Among the General Population in Singapore: Results from the Singapore Mental Health Study 2016

  2020cites this paper
• Work functioning impairment in the course of pharmacotherapy treatment for depression

  2020cites this paper
• Protocolization as a method of addressing heterogeneity in electroconvulsive therapy delivery

  2020cites this paper
• Cost-Effectiveness of Providing the Depression Care for People With Cancer Program to Patients With Prostate Cancer in the United States.

  2020cites this paper
• The Shared Decision-Making Process in the Pharmacological Management of Depression

  2019cites this paper
• Differential Diagnosis of Major Depressive Disorder Versus Bipolar Disorder: Current Status and Best Clinical Practices.

  2019cites this paper
• Periodontal status in chronic periodontitis depressed patients on desvenlafaxine: An observational study

  2018cites this paper
• Neurobiological Mechanisms of Stress Resilience and Implications for the Aged Population

  2018cites this paper
• The effect of paroxetine, venlafaxine and bupropion administration alone and combined on spatial and aversive memory performance in rats

  2018cites this paper
• A meta-analysis of the use of probiotics to alleviate depressive symptoms.

  2018cites this paper
• Clinical Use of Curcumin in Depression: A Meta-Analysis.

  2017cites this paper
• Cost-effectiveness of In-Home Cognitive Behavioral Therapy for low-income depressed mothers participating in early childhood prevention programs.

  2017cites this paper
• Troubles dépressifs

  2017cites this paper
• PATTERN OF COGNITIVE IMPAIRMENT AFTER GIVING TOTAL INTRAVENOUS ANAESTHESIA VS GENERAL ANAESTHESIA FOR ELECTROCONVULSIVE THERAPY IN PATIENTS WITH DEPRESSIVE EPISODE SEVERE

  2017cites this paper
• Clinical use of Hypericum perforatum (St John's wort) in depression: A meta-analysis.

  2017cites this paper
• [Therapeutic education for recurrent depressive disorder].

  2016cites this paper
• Physical activity and exercise attenuate neuroinflammation in neurological diseases.

  2016cites this paper
• [Vortioxetine in the treatment of major depression].

  2016cites this paper
• Effectiveness of cognitive-behavior group therapy, psycho-education family, and drug therapy in reducing and preventing recurrence of symptoms in patients with major depressive disorder

  2016cites this paper
• Éducation thérapeutique du trouble dépressif récurrent

  2016cites this paper
• Acute Continuation and Maintenance Treatment of Major Depressive Episodes With Transcranial Magnetic Stimulation.

  2016cites this paper
• Gender and brain regions specific differences in brain derived neurotrophic factor protein levels of depressed individuals who died through suicide.

  2015cites this paper
• Bilateral repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and meta-analysis of randomized controlled trials

  2015cites this paper
• Prevalence and correlates of major depressive disorder among rural-to-urban migrant workers in Shenzhen, China.

  2015cites this paper
• Should women be screened for postnatal depression? Exploring the effects of undiagnosed maternal mental health problems on child development.

  2014cites this paper
• Depression : can we predict who will relapse?

  2014cites this paper
• Evaluation of a Booster Intervention Three Years After Acute Treatment for Early-Onset Disruptive Behavior Disorders

  2014cites this paper
• The efficacy of vortioxetine for the treatment of major depressive disorder

  2014cites this paper
• Risk factors for incidence and persistence of disability in chronic major depression and alcohol use disorders: Longitudinal analyses of a population-based study

  2014cites this paper
• Long-term fluoxetine treatment induces input-specific LTP and LTD impairment and structural plasticity in the CA1 hippocampal subfield

  2013cites this paper
• Evaluation of a Booster Intervention Three Years After Acute Treatment for Early-Onset Disruptive Behavior Disorders

  2013cites this paper
• Can effects of antidepressants in patients with mild depression be considered as clinically significant?

  2012cites this paper
• Efeito dos Antidepressivos a Longo Prazo Experiência Profissionalizante na Vertente de Farmácia Comunitária e Investigação

  2012cites this paper
• Are antidepressants useful in the treatment of minor depression: a critical update of the current literature

  2012cites this paper
• Duration of response after treatment of mild to moderate depression with Hypericum extract STW 3-VI, citalopram and placebo: a reanalysis of data from a controlled clinical trial.

  2011cites this paper
• A Systematic Review of the Combined Use of Electroconvulsive Therapy and Psychotherapy for Depression

  2011cites this paper
• Psychopharmako- und Psychotherapie bei Patienten mit minorer Depression

  2011cites this paper
• Study of a primary care depression relapse prevention program: "keeping the blues away".

  2010cites this paper
• Effects of severe mental illness on bone mineral density and body composition

  2010cites this paper
• Recurrence of sickness absence due to common mental disorders

  2010cites this paper
• Agomelatine in the treatment of major depressive disorder

  2010cites this paper
• The clinical significance of antidepressant treatment effects cannot be derived from placebo-verum response differences

  2010cites this paper
• Gender and age differences in the recurrence of sickness absence due to common mental disorders: a longitudinal study

  2010cites this paper
• Evidence-Based Practice Problems: Form and Focus

  2010cites this paper
• From synapse to nucleus: novel targets for treating depression.

  2010cites this paper
• Long-term outcome of anxiety disorders: a review of double-blind studies

  2009cites this paper
• Outcomes in major depressive disorder: The evolving concept of remission and its implications for treatment

  2008cites this paper
• Antidepressiva

  2008cites this paper
• Brief report: Characteristics of antidepressant use in patients with heart failure

  2008cites this paper
• Pharmacogenomics Applications in Psychiatric Disorders

  2008cites this paper
• Quetiapine treatment for mania secondary to brain injury in 2 patients.

  2008cites this paper
• Aktuální trendy v léčbě závažných psychických poruch

  2008cites this paper
• Treating schizophrenia with comorbid depressive or demoralization symptoms.

  2008cites this paper
• Misdiagnosis of bipolar II disorder as major depressive disorder.

  2008cites this paper
• El suicidio y algunos de sus correlatos neurobiológicos. Segunda parte

  2008cites this paper
• Urinary retention associated with ziprasidone: a case report.

  2008cites this paper
• Gender imbalance in clinical trials in schizophrenia.

  2008cites this paper
• Association of fish and long-chain n-3 polyunsaturated fatty acid intakes with the occurrence of depressive episodes in middle-aged French men and women.

  2008cites this paper
• Adult ADHD : When Comorbid Depression Enters

  2007cites this paper
• Trials Open Access Rationale, Design and Methodology of a Double-blind, Randomized, Placebo-controlled Study of Escitalopram in Prevention of Depression in Acute Coronary Syndrome (decard)

  year unknowncites this paper